Skip to main content
. 2022 Apr 20;97(7):877–884. doi: 10.1002/ajh.26566

FIGURE 2.

FIGURE 2

Overall survival and hematological response. Overall survival in the groups with amyloidosis‐associated monoclonal gammopathy of renal significance (A) and non‐amyloidosis‐associated gammopathy of renal significance (B) depending on hematological response.* ‐ Hazard ratio for comparison between survival of patients with ≥VGPR versus ≤PR or PD [Color figure can be viewed at wileyonlinelibrary.com]